InvestSMART

Opyl Limited (ASX: OPL) - Announcements

- Current share price for OPL : $0.022

ASX company news and announcements for Opyl Limited (OPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Opyl Limited (OPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Opyl Limited (OPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Opyl Limited (OPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Opyl - Port Jackson Securities Webinar 8 Sep 2021 9:26AM $0.140 $0.022 fallen by 84.29%
- Opyl - August Full Year Investor Update 30 Aug 2021 11:11AM $0.150 $0.022 fallen by 85.33%
- Opyl 2021 Appendix 4G & Corporate Governance Statement 27 Aug 2021 9:29AM $0.140 $0.022 fallen by 84.29%
- Opyl 2021 Appendix 4E & Annual Report 27 Aug 2021 9:29AM $0.140 $0.022 fallen by 84.29%
- Opyl - Investor Webinar - Monday 30 August 2021 25 Aug 2021 10:02AM $0.140 $0.022 fallen by 84.29%
- Notification regarding unquoted securities - OPL 6 Aug 2021 9:26AM $0.150 $0.022 fallen by 85.33%
- Opyl - Business Update & Appendix 4C 29 Jul 2021 9:41AM $0.155 $0.022 fallen by 85.81%
- Opyl - Opin enters global strategic alliance 2 Jul 2021 9:52AM $0.175 $0.022 fallen by 87.43%
- Opyl - Change of Director's Interest Notice - M Basyrov 22 Jun 2021 9:31AM $0.190 $0.022 fallen by 88.42%
- Opyl - Investor presentation introducing Opin 24 May 2021 12:55PM $0.275 $0.022 fallen by 92%
- Introducing Opin - match patients to clinical trials 21 May 2021 9:49AM $0.220 $0.022 fallen by 90%
- Opyl - Clarification Statement to Appendix 4C 19 May 2021 11:41AM $0.210 $0.022 fallen by 89.52%
- Opyl Initial Directors Interest Notice - Dr Megan Robertson 5 May 2021 1:51PM $0.195 $0.022 fallen by 88.72%
- Opyl appoints Dr Megan Robertson to its Board 5 May 2021 1:26PM $0.195 $0.022 fallen by 88.72%
- Opyl - Business Update & Appendix 4C 30 Apr 2021 9:43AM $0.205 $0.022 fallen by 89.27%
- Opyl Appendix 3Y Change of Director's Interest - D Rasheed 28 Apr 2021 12:02PM $0.200 $0.022 fallen by 89%
- Opyl Appendix 3Y Change of Director's Interest - J Chick 28 Apr 2021 12:02PM $0.200 $0.022 fallen by 89%
- Opyl - Appendix 2A 21 Apr 2021 1:40PM $0.225 $0.022 fallen by 90.22%
- Opyl - Completes successful SPP 21 Apr 2021 1:40PM $0.225 $0.022 fallen by 90.22%
- Opyl - Updated Link for Webinar Registration 16 Apr 2021 9:48AM $0.185 $0.022 fallen by 88.11%
- Opyl - Clinical trial recruitment platform update 15 Apr 2021 9:44AM $0.180 $0.022 fallen by 87.78%
- Opyl - Completes Unmarketable Share Buyback 9 Apr 2021 9:29AM $0.205 $0.022 fallen by 89.27%
- Opyl - Appendix 2A 6 Apr 2021 4:08PM $0.175 $0.022 fallen by 87.43%
- Opyl - Capital Raising Completed & Cleansing Notice 6 Apr 2021 4:08PM $0.175 $0.022 fallen by 87.43%
- Proposed issue of Securities - OPL 30 Mar 2021 11:15AM $0.180 $0.022 fallen by 87.78%

326 - 350 of 540 results

Page 14 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.